Merit Financial Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $733K | Buy |
4,083
+522
| +15% | +$93.8K | 0.01% | 923 |
|
|
2025
Q1 | $603K | Buy |
3,561
+1,109
| +45% | +$188K | 0.01% | 850 |
|
|
2024
Q4 | $370K | Buy |
2,452
+696
| +40% | +$105K | 0.01% | 838 |
|
|
2024
Q3 | $273K | Sell |
1,756
-304
| -15% | -$47.2K | 0.01% | 696 |
|
|
2024
Q2 | $282K | Sell |
2,060
-4,346
| -68% | -$595K | 0.01% | 750 |
|
|
2024
Q1 | $880K | Sell |
6,406
-425
| -6% | -$58.4K | 0.02% | 438 |
|
|
2023
Q4 | $942K | Buy |
6,831
+386
| +6% | +$53.2K | 0.03% | 331 |
|
|
2023
Q3 | $785K | Buy |
6,445
+176
| +3% | +$21.4K | 0.03% | 365 |
|
|
2023
Q2 | $881K | Buy |
6,269
+89
| +1% | +$12.5K | 0.03% | 356 |
|
|
2023
Q1 | $874K | Buy |
6,180
+77
| +1% | +$10.9K | 0.03% | 301 |
|
|
2022
Q4 | $955K | Buy |
+6,103
| New | +$955K | 0.03% | 305 |
|